Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia.

Bounthavong, Mark; Butler, Javed; Dolan, Chantal M; Dunn, Jeffrey D; Fisher, Kathryn A; Oestreicher, Nina; Pitt, Bertram; Hauptman, Paul J; Veenstra, David L

Bounthavong, Mark; Butler, Javed; Dolan, Chantal M; Dunn, Jeffrey D; Fisher, Kathryn A; Oestreicher, Nina; Pitt, Bertram; Hauptman, Paul J; Veenstra, David L.

Afiliación

Bounthavong M; Department of Pharmacy, University of Washington, 1959 NE Pacific St, HSB H375-P, Box 357630, Seattle, WA, 98195-7630, USA.
Butler J; Division of Cardiology, Stony Brook University, Stony Brook, NY, USA.
Dolan CM; CMD Consulting, Sandy, UT, USA.
Dunn JD; Magellan Rx, Salt Lake City, UT, USA.
Fisher KA; CMD Consulting, Sandy, UT, USA.
Oestreicher N; Epidemiology, HEOR and Observational Research, Relypsa, Inc., a Vifor Pharma Group Company, Redwood City, CA, USA.
Pitt B; Department of Clinical Pharmacy, University of California, San Francisco, CA, USA.
Hauptman PJ; University of Michigan School of Medicine, Ann Arbor, MI, USA.
Veenstra DL; Division of Cardiology, Department of Medicine, Saint Louis University School of Medicine, Saint Louis, MI, USA.

Pharmacoeconomics ; 37(8): 1071, 2019 Aug.

Article en En | MEDLINE | ID: mdl-31089966

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Revista: Pharmacoeconomics Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google